Madrigal Pharmaceuticals (MDGL) Assets Average (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) posted quarterly Assets Average of $1.2 billion for Q2 2026, up 22.86% year-over-year from $1.0 billion in Q2 2025, and down 0.6% quarter-over-quarter from $1.2 billion in Q1 2026.
Madrigal Pharmaceuticals (MDGL) Assets Average (2011 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Assets Average for 16 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets Average rose 22.86% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (up 22.86% YoY), while the FY2025 annual figure was $1.2 billion, up 36.79% from the prior year.
- Assets Average retreated to $1.2 billion in Q2 2026 per MDGL's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.3 billion in Q4 2025 and bottomed at $187.5 million in Q3 2022.
- Historically, Assets Average has averaged $744.0 million across 5 years, with a median of $933.7 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average slumped 40.72% — and 2024, when it surged 302.1%.
- Madrigal Pharmaceuticals' Assets Average stood at $260.6 million in 2022, then jumped by 68.55% to $439.3 million in 2023, then jumped by 140.81% to $1.1 billion in 2024, then climbed by 23.94% to $1.3 billion in 2025, then decreased by 5.72% to $1.2 billion in 2026.
- Business Quant data shows MDGL's Assets Average at $1.2 billion in Q2 2026, $1.2 billion in Q1 2026, and $1.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | 1.24 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Bn |
| Mar 31, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.31 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.01 Bn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.06 Bn |
| Sep 30, 2024 | 1.09 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 861.41 Mn |
| Dec 31, 2023 | 439.26 Mn |
| Sep 30, 2023 | 270.21 Mn |
| Jun 30, 2023 | 317.46 Mn |
| Mar 31, 2023 | 347.51 Mn |
| Dec 31, 2022 | 260.61 Mn |
| Sep 30, 2022 | 187.52 Mn |
| Jun 30, 2022 | 219.53 Mn |
| Mar 31, 2022 | 248.00 Mn |
| Dec 31, 2021 | 289.01 Mn |
| Sep 30, 2021 | 316.33 Mn |